HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,786: | Line 1,786: | ||
|- | |- | ||
|[[HAEM5:Primary cutaneous diffuse large B-cell lymphoma, leg type|Primary cutaneous diffuse large B-cell lymphoma, leg type]]||Disease|| || || || || ||GC|| || | |[[HAEM5:Primary cutaneous diffuse large B-cell lymphoma, leg type|Primary cutaneous diffuse large B-cell lymphoma, leg type]]||Disease|| || || || || ||GC|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Intravascular large B-cell lymphoma|Intravascular large B-cell lymphoma]]||Disease|| || || || || ||GC|| || | |[[HAEM5:Intravascular large B-cell lymphoma|Intravascular large B-cell lymphoma]]||Disease|| || || || || ||GC|| || | ||
| | |Intravascular Large B-cell Lymphoma | ||
|Kate Berry, MBBS, BBus (Hons), Pathology Queensland | |Kate Berry, MBBS, BBus (Hons), Pathology Queensland, Greg Corboy | ||
| | |Complete | ||
| | |9/1/22 | ||
| | |Emailed 28/3/2022 for progress update | ||
|- | |- | ||
|[[HAEM5:Primary mediastinal large B-cell lymphoma|Primary mediastinal large B-cell lymphoma]]||Disease|| || || || || ||GC|| || | |[[HAEM5:Primary mediastinal large B-cell lymphoma|Primary mediastinal large B-cell lymphoma]]||Disease|| || || || || ||GC|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Mediastinal grey zone lymphoma|Mediastinal grey zone lymphoma]]||Disease|| || || || || ||GC|| || | |[[HAEM5:Mediastinal grey zone lymphoma|Mediastinal grey zone lymphoma]]||Disease|| || || || || ||GC|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:High-grade B-cell lymphoma, NOS|High-grade B-cell lymphoma, NOS]]||Disease|| || || || || ||GC|| || | |[[HAEM5:High-grade B-cell lymphoma, NOS|High-grade B-cell lymphoma, NOS]]||Disease|| || || || || ||GC|| || | ||
| | |High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) | ||
|Aiko Otsubo, PhD, Indiana University | |Aiko Otsubo, PhD, Indiana University, Holli Drendel | ||
| | |Complete | ||
| | |16/11/2021 | ||
| | | | ||
|- | |- | ||